# A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis

> **NCT03963401** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 219 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** PF-06700841
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03963401
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-13
- **Primary completion:** 2020-04-06
- **Final completion:** 2021-01-15
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2021-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963401, "A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03963401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*